HSPG2 and Alzheimer disease: Chromatofocusing profiling showed a significant reduction of PLC γ1 and a concomitant increase of phospholipase Cδ1 activity in AD brains compared with controls, suggesting that the involvement of PLC isozymes in AD is different [146].